|
Video: What is a Stock Split?
|
|
Amarin a pharmaceutical company that focused on the commercialization and development of therapeutics to improve cardiovascular health. Co.'s primary product, Vascepa® (icosapent ethyl) capsules, is use as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. The U.S. Food and Drug Administration (FDA) approved an indication and label for Vascepa based on the results of Co.'s cardiovascular outcomes trial of Vascepa, REDUCE-IT® (Reduction of Cardiovascular Events with EPA – Intervention Trial). Vascepa is approved by the FDA as an adjunct to tolerated statin therapy for reducing persistent cardiovascular risk in select high risk patients. According to our AMRN split history records, Amarin has had 1 split. | |
|
Amarin (AMRN) has 1 split in our AMRN split history database. The split for AMRN took place on October 19, 1998. This was a 1 for 10
reverse split, meaning for each 10
shares of AMRN owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.
When a company such as Amarin conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the AMRN split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Amarin shares, starting with a $10,000 purchase of AMRN, presented on a split-history-adjusted basis factoring in the complete AMRN split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
10/09/2014 |
|
End date: |
10/07/2024 |
|
Start price/share: |
$0.98 |
|
End price/share: |
$0.58 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-40.82% |
|
Average Annual Total Return: |
-5.11% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$5,917.55 |
|
Years: |
10.00 |
|
|
|
Date |
Ratio |
10/19/1998 | 1 for 10
|
|
|